Agarose Surface Coating Influences Intracellular Accumulation and Enhances Payload Stability of a Nano-delivery System
Protein therapeutics often require repeated administrations of drug over a long period of time. Protein instability is a major obstacle to the development of systems for their controlled and sustained release. We describe a surface modification of nanoporous silicon particles (NSP) with an agarose hydrogel matrix that enhances their ability to load and release proteins, influencing intracellular delivery and preserving molecular stability.
We developed and characterized an agarose surface modification of NSP. Stability of the released protein after enzymatic treatment of loaded particles was evaluated with SDS-page and HPLC analysis. FITC-conjugated BSA was chosen as probe protein and intracellular delivery evaluated by fluorescence microscopy.
We showed that agarose coating does not affect NSP protein release rate, while fewer digestion products were found in the released solution after all the enzymatic treatments. Confocal images show that the hydrogel coating improves intracellular delivery, specifically within the nucleus, without affecting the internalization process.
This modification of porous silicon adds to its tunability, biocompatibility, and biodegradability the ability to preserve protein integrity during delivery without affecting release rates and internalization dynamics. Moreover, it may allow the silicon particles to function as protein carriers that enable control of cell function.
KEY WORDSagarose hydrogel intracellular delivery nanopores porous silicon protein
agarose composition 0.125%
agarose composition 0.05%
bovine serum albumin
fluorescence activated cell sorting
fibroblast growth factor
high performance liquid chromatography
human umbilical vein endothelial cells
bare / not coated
nanoporous silicon particles
sodium dodecyl sulfate polyacrylamide gel electrophoresis
scanning electron microscope
vascular endothelial growth factor
- 3.Chen DJ, Osterrieder N, Metzger SM, Buckles E, Doody AM, DeLisa MP, et al. Delivery of foreign antigens by engineered outer membrane vesicle vaccines. Proc Natl Acad Sci. 107:3099–3104.Google Scholar
- 25.Canham LT. Bioactive silicon structure fabrication through nanoetching techniques. Advanced Materials. 1995; 7.Google Scholar
- 26.Voelcker NH, Khung Y-L, Low SP, Clements LR, Williams KA. Porous Silicon Science and Technology Conference, Valencia, 2010.Google Scholar
- 27.Herino R. In: Canham LT, editor. The properties of porous silicon. London: INSPEC-IEE; 1997.Google Scholar
- 38.Serda RE, Godin B, Blanco E, Chiappini C, Ferrari M. Multi-stage delivery nano-particle systems for therapeutic applications. Biochimica et Biophysica Acta (BBA)—General Subjects. In Press, Corrected Proof:in press (2010).Google Scholar
- 44.Ferrari M. Nanogeometry Beyond drug delivery Nat Nano. 2008;3:131–2.Google Scholar
- 45.Godin B, Gu J, Serda RE, Bhavane R, Tasciotti E, Chiappini C, et al. Tailoring the degradation kinetics of mesoporous silicon structures through PEGylation. J Biomed Mater Res A. 2010;94A:1236–43.Google Scholar